Authors:
Roux-Lombard, P
Eberhardt, K
Saxne, T
Dayer, JM
Wollheim, FA
Citation: P. Roux-lombard et al., Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation inearly rheumatoid arthritis. A prospective 5-year study, RHEUMATOLOG, 40(5), 2001, pp. 544-551
Authors:
Mansson, B
Gulfe, A
Geborek, P
Heinegard, D
Saxne, T
Citation: B. Mansson et al., Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis, ANN RHEUM D, 60(1), 2001, pp. 27-31
Authors:
Scheja, A
Wildt, M
Wollheim, FA
Akesson, A
Saxne, T
Citation: A. Scheja et al., Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement, RHEUMATOLOG, 39(10), 2000, pp. 1110-1113
Citation: P. Geborek et T. Saxne, Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis, RHEUMATOLOG, 39(10), 2000, pp. 1159-1161
Authors:
Salminen, H
Perala, M
Lorenzo, P
Saxne, T
Heinegard, D
Saamanen, AM
Vuorio, E
Citation: H. Salminen et al., Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis, ARTH RHEUM, 43(8), 2000, pp. 1742-1748
Citation: B. Mansson et al., Diagnosis of osteoarthritis in relation to molecular processes in cartilage: comment on the article by Clark et al, ARTH RHEUM, 43(6), 2000, pp. 1425-1426
Authors:
Joosten, LAB
Helsen, MMA
Saxne, T
Heinegard, D
van de Putte, LBA
van den Berg, WB
Citation: Lab. Joosten et al., Synergistic protection against cartilage destruction by low dose prednisolone and interleukin-10 in established murine collagen arthritis, INFLAMM RES, 48(1), 1999, pp. 48-55
Authors:
Bergstrom, U
Book, C
Lindroth, Y
Marsal, L
Saxne, T
Jacobsson, L
Citation: U. Bergstrom et al., Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978, SC J RHEUM, 28(3), 1999, pp. 160-165
Authors:
Joosten, LAB
Helsen, MMA
Saxne, T
van de Loo, FAJ
Heinegard, D
van den Berg, WB
Citation: Lab. Joosten et al., IL-1 alpha beta blockade prevents cartilage and bone destruction in murinetype II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation, J IMMUNOL, 163(9), 1999, pp. 5049-5055
Authors:
Bleasel, JF
Poole, AR
Heinegard, D
Saxne, T
Holderbaum, D
Ionescu, M
Jones, P
Moskowitz, RW
Citation: Jf. Bleasel et al., Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation, ARTH RHEUM, 42(1), 1999, pp. 39-45